BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24495954)

  • 21. Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders.
    Yang Y; Song R; Gao Y; Yu H; Wang S
    Mol Med; 2023 Jun; 29(1):80. PubMed ID: 37365502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of COP9 signalosome in cancer.
    Lee MH; Zhao R; Phan L; Yeung SC
    Cell Cycle; 2011 Sep; 10(18):3057-66. PubMed ID: 21876386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
    Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
    J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSN5/Jab1 mutations affect axis formation in the Drosophila oocyte by activating a meiotic checkpoint.
    Doronkin S; Djagaeva I; Beckendorf SK
    Development; 2002 Nov; 129(21):5053-64. PubMed ID: 12397113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JAB1/CSN5: a new player in cell cycle control and cancer.
    Shackleford TJ; Claret FX
    Cell Div; 2010 Oct; 5():26. PubMed ID: 20955608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5.
    Wei Y; Liu G; Wu B; Yuan Y; Pan Y
    Cell Physiol Biochem; 2018; 47(5):2126-2135. PubMed ID: 29975923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-linked intellectual disability gene CUL4B targets Jab1/CSN5 for degradation and regulates bone morphogenetic protein signaling.
    He F; Lu D; Jiang B; Wang Y; Liu Q; Liu Q; Shao C; Li X; Gong Y
    Biochim Biophys Acta; 2013 May; 1832(5):595-605. PubMed ID: 23357576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired DNA damage checkpoint response in MIF-deficient mice.
    Nemajerova A; Mena P; Fingerle-Rowson G; Moll UM; Petrenko O
    EMBO J; 2007 Feb; 26(4):987-97. PubMed ID: 17290223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JAB1/CSN5 interacts with the GAL4 DNA binding domain: a note of caution about two-hybrid interactions.
    Nordgård O; Dahle Ø; Andersen TØ; Gabrielsen OS
    Biochimie; 2001 Oct; 83(10):969-71. PubMed ID: 11728635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The β-catenin E3 ubiquitin ligase SIAH-1 is regulated by CSN5/JAB1 in CRC cells.
    Jumpertz S; Hennes T; Asare Y; Vervoorts J; Bernhagen J; Schütz AK
    Cell Signal; 2014 Sep; 26(9):2051-9. PubMed ID: 24882689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jab1 has negative effects on p53-mediated genotoxic stresses.
    Lee EW; Lee S; Song J
    BMB Rep; 2009 May; 42(5):299-303. PubMed ID: 19470245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation.
    Kim BC; Lee HJ; Park SH; Lee SR; Karpova TS; McNally JG; Felici A; Lee DK; Kim SJ
    Mol Cell Biol; 2004 Mar; 24(6):2251-62. PubMed ID: 14993265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair.
    Tian L; Peng G; Parant JM; Leventaki V; Drakos E; Zhang Q; Parker-Thornburg J; Shackleford TJ; Dai H; Lin SY; Lozano G; Rassidakis GZ; Claret FX
    Oncogene; 2010 Nov; 29(46):6125-37. PubMed ID: 20802511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting.
    Liu Y; Shah SV; Xiang X; Wang J; Deng ZB; Liu C; Zhang L; Wu J; Edmonds T; Jambor C; Kappes JC; Zhang HG
    Am J Pathol; 2009 Apr; 174(4):1415-25. PubMed ID: 19246649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
    Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response.
    Lee YH; Judge AD; Seo D; Kitade M; Gómez-Quiroz LE; Ishikawa T; Andersen JB; Kim BK; Marquardt JU; Raggi C; Avital I; Conner EA; MacLachlan I; Factor VM; Thorgeirsson SS
    Oncogene; 2011 Oct; 30(40):4175-84. PubMed ID: 21499307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of CSN5 promotes the apoptosis of gastric cancer cells through regulating p53-related apoptotic pathways.
    Sang MM; Du WQ; Zhang RY; Zheng JN; Pei DS
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2897-901. PubMed ID: 26048783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression pattern of the JAB1/CSN5 gene during murine embryogenesis: colocalization with NEDD8.
    Carrabino S; Carminati E; Talarico D; Pardi R; Bianchi E
    Gene Expr Patterns; 2004 Jul; 4(4):423-31. PubMed ID: 15183309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S100A7, Jab1, and p27
    Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
    J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COP9 signalosome subunit Csn8 is involved in maintaining proper duration of the G1 phase.
    Liu C; Guo LQ; Menon S; Jin D; Pick E; Wang X; Deng XW; Wei N
    J Biol Chem; 2013 Jul; 288(28):20443-52. PubMed ID: 23689509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.